Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 21,000 shares at $191.16 ($4.0M) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $4.0M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.03 | 916 | $173K | 4.3% |
| 2 | $189.03 | 916 | $173K | 4.3% |
| 3 | $190.01 | 3,084 | $586K | 14.6% |
| 4 | $190.01 | 3,084 | $586K | 14.6% |
| 5 | $191.16 | 3,000 | $573K | 14.3% |
| 6 | $192.12 | 4,500 |
| $865K |
| 21.5% |
| 7 | $192.97 | 5,100 | $984K | 24.5% |
| 8 | $193.64 | 400 | $77K | 1.9% |
| Total | $191.33 avg | 21,000 | $4.0M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |